![Heidi Kempinski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Heidi Kempinski
Operationeel Directeur bij Aegle Therapeutics Corp.
Actieve functies van Heidi Kempinski
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Aegle Therapeutics Corp.
![]() Aegle Therapeutics Corp. BiotechnologyHealth Technology Aegle Therapeutics Corp. is a biotechnology company, which isolates extracellular vesicles including exosomes (“EVs”) secreted by allogeneic bone marrow derived mesenchymal stem cells to treat dystrophic epidermolysis bullosa (“DEB”), a rare pediatric connective tissue disorder. Its EV therapy has the potential to demonstrate a safer, lower cost means of harnessing the regenerative healing power of stem cells without using the cells. The company was founded by Evangelos V. Badiavas, and Robert F. Williamson III in 2013 and is headquartered in Miami, FL. | Operationeel Directeur | 29-09-2020 | - |
Tellus Bioventures LLC
![]() Tellus Bioventures LLC Investment ManagersFinance Tellus BioVentures LLC (Tellus BioVentures) is a venture capital firm founded in 2019 by Leon O. Moulder. The firm is headquartered in Miromar Lakes, Florida. | Private Equity Investor | 01-08-2020 | - |
Praeventix, Inc.
![]() Praeventix, Inc. BiotechnologyHealth Technology Praeventix, Inc. is a biotechnology company founded by Dr. Douglas Pippin based on discoveries researched by Dr. Pippin and at Temple University. The company is based in Exton, PA, and was founded by Douglas Pippin. The company is initially focused on the development of pre-clinical candidate pra-523, a potential first-in-class neuromodulatory therapy for pruritus and other potential indications, including IBD. Praeventix is pursuing novel serotonergic therapeutics for inflammatory bowel disease (IBD) and cocaine use disorder (CUD). Douglas Pippin has been the CEO since incorporation. | Operationeel Directeur | - | - |
Loopbaan van Heidi Kempinski
Eerdere bekende functies van Heidi Kempinski
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
GSK PLC | Corporate Officer/Principal | 01-01-2019 | 01-07-2020 |
TESARO INC | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
Verenigde Staten | 5 |
Verenigd Koninkrijk | 2 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Operating Officer | 2 |
Private Equity Investor | 1 |
Sectoraal
Health Technology | 5 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GSK PLC | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Tesaro, Inc.
![]() Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Aegle Therapeutics Corp.
![]() Aegle Therapeutics Corp. BiotechnologyHealth Technology Aegle Therapeutics Corp. is a biotechnology company, which isolates extracellular vesicles including exosomes (“EVs”) secreted by allogeneic bone marrow derived mesenchymal stem cells to treat dystrophic epidermolysis bullosa (“DEB”), a rare pediatric connective tissue disorder. Its EV therapy has the potential to demonstrate a safer, lower cost means of harnessing the regenerative healing power of stem cells without using the cells. The company was founded by Evangelos V. Badiavas, and Robert F. Williamson III in 2013 and is headquartered in Miami, FL. | Health Technology |
Tellus Bioventures LLC
![]() Tellus Bioventures LLC Investment ManagersFinance Tellus BioVentures LLC (Tellus BioVentures) is a venture capital firm founded in 2019 by Leon O. Moulder. The firm is headquartered in Miromar Lakes, Florida. | Finance |
Praeventix, Inc.
![]() Praeventix, Inc. BiotechnologyHealth Technology Praeventix, Inc. is a biotechnology company founded by Dr. Douglas Pippin based on discoveries researched by Dr. Pippin and at Temple University. The company is based in Exton, PA, and was founded by Douglas Pippin. The company is initially focused on the development of pre-clinical candidate pra-523, a potential first-in-class neuromodulatory therapy for pruritus and other potential indications, including IBD. Praeventix is pursuing novel serotonergic therapeutics for inflammatory bowel disease (IBD) and cocaine use disorder (CUD). Douglas Pippin has been the CEO since incorporation. | Health Technology |
- Beurs
- Insiders
- Heidi Kempinski
- Ervaring